Rapid7 to Present at Upcoming Investor Conferences

BOSTON, May 07, 2019 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leading provider of security analytics and automation, today announced that management will present at the following investor conferences.

• The Needham Emerging Technology Conference in New York, NY. The presentation is scheduled for Wednesday, May 22, 2019 at 2:30 p.m, Eastern Time.  
• The Cowen and Company Technology, Media & Telecom Conference in New York, NY. The presentation is scheduled for Wednesday, May 29, 2019 at 9:40 a.m. Eastern Time. 
• The William Blair Growth Stock Conference in Chicago, IL. The presentation is scheduled for Thursday, June 6, 2019 at 8:00 a.m. Central Time. 
• The Stifel Cross Sector Insight Conference in Boston, MA. The presentation is scheduled for Tuesday, June 11, 2019 at 1:15 p.m. Eastern Time.

The presentations will be webcast live, and replays will be available for a limited time under the “Events and Presentations” section on the Company’s investor relations website at investors.rapid7.com.

About Rapid7Rapid7 (Nasdaq: RPD) is advancing security with visibility, analytics, and automation delivered through our Insight cloud. Our solutions simplify the complex, allowing security teams to work more effectively with IT and development to reduce vulnerabilities, monitor for malicious behavior, investigate and shut down attacks, and automate routine tasks. Over 7,900 customers rely on Rapid7 technology, services, and research to improve security outcomes and securely advance their organizations. For more information, visit our website, check out our blog, or follow us on Twitter.

Investor Contact:Neeraj Mahajan, CFAVice President, Investor Relations[email protected](857) 990-4074

Press contact:Caitlin DohertyPublic Relations Manager[email protected](857) 990-4240

You May Also Be Interested In

• Needham says State AGs delay on Paramount Skydance (PSKY) deal 'will NOT derail the deal'
• Artelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026
• Alto Neuroscience prices $100M stock offering to fund depression trial